drugset / Trial / NCT01437306
Lofexidine Food Effect Study in Healthy Volunteers
Phase 1
Completed
13 enrolled
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverOpen-labelBasic science
Summary
The objective of this single-dose, open-label, randomized, two-period, two-way crossover, food-effect study is to evaluate the effect of food on the rate of absorption and oral bioavailability of a test formulation of lofexidine 400 μg (2 x 200 μg tablet) manufactured by US WorldMeds, LLC.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lofexidine | Small molecule | 400 ug | Oral |
Indications
No indication recorded.